Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.17 is 75% below its 5-year average of 4.64, near the low end of its 5-year range (1.17–6.92).
As of the fiscal period ended Tuesday, June 30, 2026. 58.11% below its 12-month average of 2.79.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.17.
QUICK RATIO (ACID-TEST)
1.17
QUICK RATIO (ACID-TEST) AVG TTM
2.79
QUICK RATIO (ACID-TEST) AVG 3Y
3.79
QUICK RATIO (ACID-TEST) AVG 5Y
4.64
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-58.11%
CURRENT VS 3Y AVG
-69.18%
CURRENT VS 5Y AVG
-74.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.79
median of 371 covered companies
CURRENT VS SECTOR MEDIAN
-58.14%
vs the sector median at left
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Quick Ratio (Acid-Test)
1.17
TTM Avg
2.79
3Y Avg
3.79
5Y Avg
4.64
Market Cap
$12.89B
Quick Ratio (Acid-Test)
0.95
TTM Avg
1.18
3Y Avg
1.19
5Y Avg
1.30
Market Cap
$13.19B
Quick Ratio (Acid-Test)
2.77
TTM Avg
3.05
3Y Avg
4.30
5Y Avg
5.45
Market Cap
$12.52B
Quick Ratio (Acid-Test)
1.32
TTM Avg
1.31
3Y Avg
1.23
5Y Avg
1.40
Market Cap
$12.17B
Quick Ratio (Acid-Test)
1.22
TTM Avg
1.00
3Y Avg
0.95
5Y Avg
1.02
Market Cap
$12.00B
Quick Ratio (Acid-Test)
1.19
TTM Avg
1.06
3Y Avg
1.17
5Y Avg
1.20
Market Cap
$14.16B
Quick Ratio (Acid-Test)
2.32
TTM Avg
0.80
3Y Avg
0.84
5Y Avg
4.11
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | 1.17 | 2.79 | 3.79 | 4.64 |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.95 | 1.18 | 1.19 | 1.30 |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 2.77 | 3.05 | 4.30 | 5.45 |
| Baxter International Inc. (BAX)vs › | $12.52B | 1.32 | 1.31 | 1.23 | 1.40 |
| Penumbra, Inc. (PEN)vs › | $12.49B | 3.86 | 3.87 | 3.53 | 3.55 |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 1.22 | 1.00 | 0.95 | 1.02 |
| Encompass Health Corporation (EHC)vs › | $12.00B | 1.19 | 1.06 | 1.17 | 1.20 |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 2.32 | 0.80 | 0.84 | 4.11 |
| DaVita Inc. (DVA)vs › | $11.47B | 1.41 | 1.23 | 1.19 | 1.21 |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 3.35 | 2.87 | 2.99 | 2.87 |
Quick Ratio
1.17
Excludes inventory
Current Ratio
1.23
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.17 |
| 2026-03-31 | 1.40 |
| 2025-12-31 | 2.52 |
| 2025-09-30 | 3.76 |
| 2025-06-30 | 5.08 |
| 2025-03-31 | 4.54 |
| 2024-12-31 | 4.67 |
| 2024-09-30 | 3.19 |
| 2024-06-30 | 4.59 |
| 2024-03-31 | 5.54 |
| 2023-12-31 | 3.32 |
| 2023-09-30 | 5.54 |
| 2023-06-30 | 3.93 |
| 2023-03-31 | 5.72 |
| 2022-12-31 | 4.52 |
| 2022-09-30 | 5.39 |
| 2022-06-30 | 5.46 |
| 2022-03-31 | 6.92 |
| 2021-12-31 | 6.58 |
| 2021-09-30 | 6.68 |
| 2021-06-30 | 6.90 |
| 2021-03-31 | 9.98 |
| 2020-12-31 | 6.72 |
| 2020-09-30 | 9.85 |
| 2020-06-30 | 9.30 |
| 2020-03-31 | 14.25 |
| 2019-12-31 | 9.42 |
| 2019-09-30 | 14.00 |
| 2019-06-30 | 7.92 |
| 2019-03-31 | 10.78 |
| 2018-12-31 | 13.67 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
